Archive: 09/05/2015

Avelox approved for plague

(HealthDay)—Avelox (moxifloxacin) was approved by the U.S. Food and Drug Administration on Friday to treat plague, a rare but deadly bacterial infection that can strike the lungs (pneumonic), blood (septicemic) or lymph ...

page 1 from 2